New immunosuppressive agents in pediatric transplantation
Immunosuppressive therapy in pediatrics continues to evolve. Over the past decade, newer immunosuppressive agents have been introduced into adult and pediatric transplant patients with the goal of improving patient and allograft survival. Unfortunately, large-scale randomized clinical trials are not...
Main Authors: | Christina Nguyen, Ron Shapiro |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier España
2014-01-01
|
Series: | Clinics |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322014001300008&lng=en&tlng=en |
Similar Items
-
A Systematic Review of Adherence to Immunosuppression among Pediatric Heart Transplant Patients
by: Keira Nassetta, et al.
Published: (2022-05-01) -
Development of a predictive nomogram for switching immunosuppressive drugs in pediatric liver transplant recipients
by: Guangxiang Gu, et al.
Published: (2023-10-01) -
Immunosuppressive Therapy Protocols in Kidney Transplantation in Adults
by: Jasenko Karamehić, et al.
Published: (2006-08-01) -
Current Status Regarding Immunosuppressive Treatment in Patients after Renal Transplantation
by: Kamila Szumilas, et al.
Published: (2023-06-01) -
New immunosuppressive drugs in heart transplantation
by: Costanzo Maria Rosa
Published: (2001-02-01)